Our
results showed that 82% and 76% of the ESBL-producing isolates
were resistant to ciprofloxacine and T/S, respectively. The association
of ESBL production and resistance to fluoroquinolones and
T/S has been reported worldwide, and the widespread use of fluoroquinolones
has been identified as a risk factor for the emergence
of fluoroquinolone-resistant ESBL-producing strains